Australian Personal Products Stock News

ASX:STK
ASX:STKMetals and Mining

Strickland Metals (ASX:STK): Has Exploration Success at Rogozna Shifted Its Valuation?

Strickland Metals (ASX:STK) has caught the market’s attention after announcing several copper-gold mineral discoveries at its Rogozna Project in Serbia. Recent gravity surveys have pinpointed large-scale porphyry targets, which has prompted expanded exploration efforts. See our latest analysis for Strickland Metals. Strickland Metals’ recent copper-gold discoveries in Serbia have sparked a wave of positive momentum, reflected in the stock’s 32% jump over the past week and a remarkable...
ASX:SYR
ASX:SYRMetals and Mining

Syrah Resources (ASX:SYR) Is Up 38.3% After China Tightens Graphite Export Controls – What's Changed

Earlier this week, new Chinese export controls on graphite and lithium battery components prompted analysts at Macquarie to upgrade Syrah Resources, highlighting the company's exposure to one of the world's largest natural graphite operations. This move underscores Syrah Resources' unique position to benefit from global supply chain shifts in the graphite market amid evolving international trade policies. We'll now look at how these Chinese export restrictions could reshape Syrah's...
ASX:MEK
ASX:MEKMetals and Mining

Meeka Metals (ASX:MEK) Valuation: Assessing Prospects After Latest Full-Year Earnings Loss

Meeka Metals (ASX:MEK) just released its full-year earnings, showing a net loss of AUD 4.24 million for the year ended June 2025, up from AUD 2.94 million the prior year. The latest financials could spark fresh conversations about the company’s operational progress and market prospects. See our latest analysis for Meeka Metals. While Meeka Metals reported a wider annual loss, the share price has rallied significantly, with a 48% gain over the past three months and an eye-catching 138% rise...
ASX:PCK
ASX:PCKHealthcare Services

Should FDA De Novo Clearance for Adult App Prompt a Rethink by PainChek (ASX:PCK) Investors?

PainChek has received De Novo clearance from the US FDA for its Adult App, authorizing it as the first regulated medical device for pain assessment in individuals who cannot reliably self-report, including those with dementia, thus unlocking access to the US aged care market. The clearance not only enables immediate US commercial rollout but also paves the way for expanded opportunities in international markets that recognize FDA data standards, such as Japan and Germany. We'll now explore...
ASX:WA1
ASX:WA1Metals and Mining

WA1 Resources (ASX:WA1): Evaluating Valuation Following Strong Luni Niobium Project Progress and Positive Drill Results

WA1 Resources (ASX:WA1) has drawn market attention after releasing positive assay results from its Luni Niobium Project. The announcement confirmed the presence of high-grade niobium zones, and ongoing drilling continues to uncover more potential. See our latest analysis for WA1 Resources. WA1 Resources’ recent project milestones have clearly caught investor attention, with the share price now at A$20.80 and a strong 1-year total shareholder return of 52%. Over the past 90 days, share price...
ASX:SOL
ASX:SOLDiversified Financial

Can WHSP Holdings’ Revenue-Profit Gap Reveal New Strategic Priorities for ASX:SOL Investors?

Washington H. Soul Pattinson and Company Limited recently reported its full year results for the period ending July 31, 2025, with A$615.4 million in sales, up from A$557.6 million the previous year, but net income dropping to A$364.2 million from A$498.8 million. While sales increased, the reduction in net income and earnings per share highlights pressures on profitability despite growth in revenue. We'll explore how higher sales but lower net income in the latest results could shape the...
ASX:TUA
ASX:TUATelecom

Tuas (ASX:TUA) Valuation in Focus After AUD 50 Million Equity Raise

Tuas (ASX:TUA) has just wrapped up a follow-on equity offering, bringing in around AUD 50 million by issuing over 9 million new ordinary shares at AUD 5.51 each. Investors are watching closely as this capital injection is likely to shape Tuas’s next steps and how the market perceives its growth strategy. See our latest analysis for Tuas. Tuas shares have cooled off in the last month with a 15.5% drop, but when you zoom out, the momentum is still impressive. The past year’s total return stands...